All Type of News
Government to opt for EP regulations over biosimilar products
The Korea Food and Drug Administration is considering adopting the European regulations and guidelines in the process of screening biosimilar products.
The health regulator says the EP regulations are less stringen...
Drug makers dogged by rebate issue
Prospects have been grim for Korean pharmaceutical firms, as they are getting pressed by multinationals' increasing market presence and the government's pressure to lower drug costs. Generic drugs have long been the c...
Health ministry reaffirms rebate banThe government will stamp our pharmaceutical firms offering rebate provisions to encourage fair competition, Health and Welfare Minister Jeon Jae-hee said on September 6.
Jeo...
|
Drug wholesalers overshadowed by Samsung’s entry into logistics business
Samsung Mulsan’s advancement into the local drug logistics business has triggered concerns among drug wholesalers, according to market sources.
Sources say Samsung is likely to infiltrate into the logistics busines...
145 adverse events of Ultracet reported for 4 years
A total of 145 adverse events (AEs) have been reported during the recent four-year use of Ultracet tablets, according to Rep. Shim Jae-chul of the ruling Grand National Party who cited a report supplied by the Korea F...
Deregulation plan under fireThe government’s plan to improve the corporate environment and develop the services industry invited strong criticism from opposition lawmakers.
During a parliamentary inspec...
|
Merck Korea files patent confirmation trial over Cozaar Plus
Merck Korea says it filed to the KIPO a trial to confirm the scope of patent right pertaining to Cozaar Plus against Yuhan, Hanmi, Samil, Hanlim, Chong Kun Dang, Dong-A and Yongjin.
The Cozaar Plus patent is to las...
Production of appetite suppressants containing psychotropic substances increasing
The annual producKorea has seen an increase in its output of anorectic drugs containing psychotropic substances over the last five years.
tion values of these appetite suppressants containing pentermine or phendim...
Leading lawmaker opposes selling OTCs at supermarketsRep. Byung Woon-jeon, a leader in the Health and Welfare Committee of the National Assembly, said the government should not allow supermarket owners to sell OTCs, as this will a...
|
R&D drug technology center to open in next February
The Korea Food and Drug Administration and the National Institute of Toxicological Research has unveiled a plan to set up a R&D drug technology center in February next year in a bid to facilitate an earlier commercial...
